Federal Register / Vol. 65, No. 189 / Thursday, September 28, 2000 / Notices 58277

Massachusetts; to acquire 100 percent of

the voting shares of, and thereby merge

with Home Port Bancorp, Inc.,

Nantucket, Massachusetts, and thereby

indirectly acquire voting shares of

Nantucket Bank, Nantucket,

Massachusetts.

B. Federal Reserve Bank of Atlanta

(Cynthia C. Goodwin, Vice President)

104 Marietta Street, N.W., Atlanta,

Georgia 30303–2713:

1. Heritage Bancshares, Inc., Orange

Park, Florida; to become a bank holding

company by acquiring 100 percent of

the voting shares of Heritage Bank of

North Florida (formerly known as Clay

County Bank), Orange Park, Florida.

C. Federal Reserve Bank of Chicago

(Phillip Jackson, Applications Officer)

230 South LaSalle Street, Chicago,

Illinois 60690–1414:

1. Central Banc, Inc., Geneseo,

Illinois; to acquire 100 percent of the

voting shares of Marquette Bank Fulton,

Fulton, Illinois.

Board of Governors of the Federal Reserve

System, September 25, 2000.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 00–24937 Filed 9–27–00; 8:45 am]

BILLING CODE 6210–01–P

FEDERAL RESERVE SYSTEM

Consumer Advisory Council; Notice of

Meeting

The Consumer Advisory Council will

meet on Thursday, October 26, 2000.

The meeting, which will be open to

public observation, will take place at the

Federal Reserve Board’s offices in

Washington, DC, in Dining Room E of

the Martin Building (Terrace level). The

meeting will begin at 8:45 a.m. and is

expected to conclude at 1:00 p.m. The

Martin Building is located on C Street,

Northwest, between 20th and 21st

Streets.

The Council’s function is to advise

the Board on the exercise of the Board’s

responsibilities under the Consumer

Credit Protection Act and on other

matters on which the Board seeks its

advice. Time permitting, the Council

will discuss the following topics:

Gramm-Leach-Bliley Act CRA

Sunshine Regulation—Discussion of

issues regarding the proposal for

disclosure of CRA agreements between

financial institutions and community

groups.

Predatory Lending—Discussion of

issues resulting from the recent hearings

on the Home Ownership Equity

Protection Act.

Home Mortgage Disclosure Act—

Discussion of the possible revisions to

Regulation C which implements the

Home Mortgage Disclosure Act.

Committee Reports—Council

committees will report on their work.

Other matters previously considered

by the Council or initiated by Council

members also may be discussed.

Persons wishing to submit views to

the Council regarding any of the above

topics may do so by sending written

statements to Ann Bistay, Secretary of

the Consumer Advisory Council,

Division of Consumer and Community

Affairs, Board of Governors of the

Federal Reserve System, Washington,

DC 20551. Information about this

meeting may be obtained from Ms.

Bistay, 202–452–6470.

Telecommunications Device for the Deaf

(TDD) users may contact Diane Jenkins,

202–452–3544.

Board of Governors of the Federal Reserve

System, September 22, 2000.

Jennifer J. Johnson,

Secretary of the Board.

[FR Doc. 00–24888 Filed 9–27–00; 8:45 am]

BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Centers for Disease Control and

Prevention (CDC) Request for

Comments on Electronic Grants

(E-Grants) Plans

AGENCY: Centers for Disease Control and

Prevention (CDC), Department of Health

and Human Services (DHHS).

ACTION: Notice and request for

comments.

SUMMARY: CDC is seeking comments on

intent to develop an electronic grants

system for completing grants

transactions electronically via the

Internet.

DATES: November 27, 2000.

ADDRESSES: Centers for Disease Control

and Prevention, Attention: Jim

Seligman, E-Grants, 1600 Clifton Rd, MS

D15, Atlanta, GA 30333.

FOR FURTHER INFORMATION CONTACT: via

e-mail: CDCegrants@cdc.gov, or via

facsimile: E-Grants (attention Jim

Seligman) at 404–639–7113.

SUPPLEMENTARY INFORMATION: The

Centers for Disease Control and

Prevention (CDC) is exploring ways to

streamline and improve business

processes with the agency’s customers.

To this end, CDC is planning an

Electronic Grants (E-Grants) system to

enable the submission of electronic

grant proposals, their review, and

award. CDC is reviewing other federal

E-Grants systems for potential CDC use;

however, CDC wants to ensure that the

agency understands the needs of CDC’s

unique grants customers in determining

the best E-Grants approach for CDC.

While the primary purpose of this

request is to obtain information and

comments on CDC’s move to an

electronic grants system, other

suggestions for improving the CDC

grants process are welcome.

CDC plans to offer an electronic grants

application and review process

consistent with recent federal laws, e.g.

the Government Paperwork Elimination

Act, Public Law 105–277, Title XVII

(http://cio.gov/docs/gpea2.htm), the

Electronic Signatures in Global and

National Commerce Act, Public Law

106–229 (http://thomas.loc.gov/cgi-bin/

query/z?c106:S.761.ENR:), and the

Federal Financial Assistance

Management Improvement Act, Public

Law 106–107 (http://thomas.loc.gov/cgibin/query/z?c106:S.468.ENR:). CDC is a

participating member of the Interagency

Electronic Grants Committee (IAEGC)

(http://www.financenet.gov/iaegc.htm)

and the federal commons (http://

www.fedcommons.gov), the common

face of Government to the Grantee

Organization Community for the

purposes of pre- and post-award

administration.

Although CDC views the emergence of

Electronic Commerce (E-Commerce) as a

means of reducing the burden on

organizations as they interact with CDC,

the agency also recognizes that some of

the agency’s customers and/or potential

customers may not have the capability

to migrate to an E-Grants environment.

Therefore, CDC intends to maintain the

current paper-based interaction process

for the foreseeable future while

increasing electronic access to the

agency’s grants management processes.

Consequently, equity between nonelectronic and electronic processes will

be maintained.

Currently, CDC offers funding

application materials and related

services via fax, email, Internet listservs,

and as downloadable files or printable

forms on the Internet through CDC’s

website (http://www.cdc.gov/

funding.htm). Many U.S. Department of

Health and Human Services (DHHS)

grant application forms are now

available at (http://www.hhs.gov/

grantsnet/) on the Internet as files which

can be saved and used in electronic

formats.

As CDC moves towards increased use

of electronic announcements regarding

the availability of funds, CDC seeks to

understand unique needs and desires

58278 Federal Register / Vol. 65, No. 189 / Thursday, September 28, 2000 / Notices

among the agency’s diverse customers.

For this reason CDC requests and

welcomes comments from customers

regarding all aspects of ‘‘E-Grants’’

including but not limited to the

following areas:

IT Infrastructure

CDC business customers (grantees and

applicants) would need a computer,

printer, connection to the Internet, web

browser capable of 128-bit encrypted

secure transmissions (e.g. Microsoft

Internet Explorer version 4.01 or greater

or Netscape Communicator version 4.07

or greater, both are currently

downloadable for no cost from the

manufacturers; Microsoft: at http://

www.microsoft.com and Netscape:

http://www.netscape.com), word

processing or text editing software for

preparation of documents in a standard

format, e.g. RTF, ASCII, HTML, Adobe

Acrobat reader (downloadable for no

cost from the manufacturer at http://

www.adobe.com/), and electronic mail

service. CDC welcomes comments about

the use of these technologies.

Existing E-Grants Systems

CDC knows of existing software

available to universities which supports

grants applications and management

activities, but is unaware of which are

the leading systems currently in use in

universities. Similarly, CDC knows of

other Federal agencies beginning to use

‘‘E-Grants’’ systems. CDC is interested in

knowing whether CDC grantees and

potential applicants are using these

systems or have considered the use of

these systems and what the experience

has been. If you, or your organization

have similar plans or experiences with

E-Commerce, E-Grants, or knowledge of

the use of commercial off-the-shelf

packages, that information would be

particularly meaningful to CDC.

Electronic Forms

CDC frequently makes electronic

copies of application materials,

including standard Federal forms,

available on the web for downloading

and/or printing. CDC is interested in

whether customers find this useful or

would prefer paper forms.

E-Signature

CDC requires the use of several

assurance and certification documents

in the process to make awards. The

agency is interested in whether grantees

or potential applicants may already be

using electronic signatures in lieu of

paper-based signatures for legallybinding government grant and/or

contract activities and, if so, which

technologies.

Virtual Reviews

CDC conducts expert review of both

scientific and programmatic applicants

for funding. Reviewers are often

required to participate in review

activities on-site at the agency or within

a short distance from the agency’s

facility. CDC is interested in knowing

whether the use of distance-based

reviews conducted electronically would

impact the quality of peer reviews and

pose a barrier to or enhance the

recruitment of external reviewers for

panels, and to what extent you’ve

already participated in distance-based

reviews.

Please send comments or questions

within 60 days of this published notice:

via e-mail to: CDCegrants@cdc.gov

via facsimile to: E-Grants (attention Jim

Seligman) at 404–639–7113

via letter to: Centers for Disease Control

and Prevention, Attention: Jim

Seligman E-Grants, 1600 Clifton Rd,

MS D15, Atlanta, GA 30333.

Please provide a point of contact with

your comments for any follow-up

questions CDC may have and indicate

the type of organization you represent,

e.g. university, state government, local

government, community based

organization, etc. CDC intends to use the

information and comments received in

response to this notice in its planning

process for an electronic grants system.

No summary of comments or published

response to comments is planned. All

comments received by the agency will

be considered to be in the public

domain.

Dated: September 21, 2000.

Joseph R. Carter,

Associate Director for Management and

Operations, Centers for Disease Control and

Prevention.

[FR Doc. 00–24754 Filed 9–27–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Dental Products Panel of the Medical

Devices Advisory Committee; Notice of

Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). At least one portion of the

meeting will be closed to the public.

Name of Committee: Dental Products

Panel of the Medical Devices Advisory

Committee.

General Function of the Committee:

To provide advice and

recommendations to the agency on

FDA’s regulatory issues.

Date and Time: The meeting will be

held on October 6, 2000, 8:30 a.m. to

5:30 p.m.

Location: Corporate Bldg., conference

room 020B, 9200 Corporate Blvd.,

Rockville, MD.

Contact Person: Pamela D. Scott,

Center for Devices and Radiological

Health (HFZ–480), Food and Drug

Administration, 9200 Corporate Blvd.,

Rockville, MD 20850, 301–827–5283, or

FDA Advisory Committee Information

Line, 1–800–741–8138 (301–443–0572

in the Washington, DC area), code

12518. Please call the Information Line

for up-to-date information on this

meeting.

Agenda: The committee will discuss,

make recommendations, and vote on a

premarket approval application for a

glenoid fossa prosthesis that is used

alone to reconstruct the

temporomandibular joint (TMJ). The

committee will also discuss and make

recommendations on the labeling for a

total TMJ prosthesis.

Procedure: On October 6, 2000, from

9 a.m. to 5:30 p.m., the meeting is open

to the public. Interested persons may

present data, information, or views,

orally or in writing, on issues pending

before the committee. Written

submissions may be made to the contact

person by September 28, 2000. Oral

presentations from the public will be

scheduled between approximately 9:15

a.m. and 9:45 a.m. on October 6, 2000.

Near the end of committee

deliberations, a 30-minute open public

session will be conducted for interested

persons to address issues specific to the

submission before the committee. Time

allotted for each presentation may be

limited. Those desiring to make formal

oral presentations should notify the

contact person before September 28,

2000, and submit a brief statement of

the general nature of the evidence or

arguments they wish to present, the

names and addresses of proposed

participants, and an indication of the

approximate time requested to make

their presentation.

Closed Committee Deliberations: On

October 6, 2000, from 8:30 a.m. to 9

a.m., the meeting will be closed to

permit discussion and review of trade

secret and/or confidential commercial

information (5 U.S.C. 552b(c)(4))

regarding dental device issues.